research:early_treatment_pathways_for_chronic_conditions
Differences
This shows you the differences between two versions of the page.
| Next revision | Previous revision | ||
|
research:early_treatment_pathways_for_chronic_conditions [2014/12/06 21:50] jduke created |
research:early_treatment_pathways_for_chronic_conditions [2014/12/10 19:46] jduke |
||
|---|---|---|---|
| Line 7: | Line 7: | ||
| **Rationale:** While numerous treatment guidelines exist for chronic conditions, there is a paucity of data on the real-world treatment pathways. A recent OHDSI study explored treatment pathways for chronic conditions based on 3 years of drug exposure. Additional interest exists for looking at treatment in the early phases of a disease, where switching may often occur. Additionally, focusing the analysis on a narrower timeframe post-initiation will increase the number of eligible patients and potentially provide additional insight into these pathways. | **Rationale:** While numerous treatment guidelines exist for chronic conditions, there is a paucity of data on the real-world treatment pathways. A recent OHDSI study explored treatment pathways for chronic conditions based on 3 years of drug exposure. Additional interest exists for looking at treatment in the early phases of a disease, where switching may often occur. Additionally, focusing the analysis on a narrower timeframe post-initiation will increase the number of eligible patients and potentially provide additional insight into these pathways. | ||
| - | **Project Leads:** Jon Duke, [others please add if interested] | + | **Project Leads:** Jon Duke, Patrick Ryan, Richard Boyce, [others please add if interested] |
| - | **Coordinating Institution(s):** Regenstrief Institute | + | **Coordinating Institution(s):** Regenstrief Institute, University of Pittsburgh, Janssen |
| ** Additional Participants:** | ** Additional Participants:** | ||
research/early_treatment_pathways_for_chronic_conditions.txt ยท Last modified: 2014/12/10 19:46 by jduke
Page Tools
